Overview

The Hemodynamic Effects of PACAP38 After Glibenclamide Administration in Healthy Volunteers

Status:
Completed
Trial end date:
2021-03-19
Target enrollment:
Participant gender:
Summary
To investigate the hemodynamic effects of PACAP38 after glibenclamide administration.
Phase:
N/A
Details
Lead Sponsor:
Danish Headache Center
Treatments:
Glyburide
Pituitary Adenylate Cyclase-Activating Polypeptide